Your browser doesn't support javascript.
loading
Evaluation of the risk of venous thromboembolism after quadrivalent human papillomavirus vaccination among US females.
Yih, W Katherine; Greene, Sharon K; Zichittella, Lauren; Kulldorff, Martin; Baker, Meghan A; de Jong, Jill L O; Gil-Prieto, Ruth; Griffin, Marie R; Jin, Robert; Lin, Nancy D; McMahill-Walraven, Cheryl N; Reidy, Megan; Selvam, Nandini; Selvan, Mano S; Nguyen, Michael D.
Afiliación
  • Yih WK; Harvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA, USA. Electronic address: katherine_yih@harvardpilgrim.org.
  • Greene SK; Harvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA, USA.
  • Zichittella L; Harvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA, USA.
  • Kulldorff M; Harvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA, USA.
  • Baker MA; Harvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA, USA.
  • de Jong JL; Department of Pediatrics, University of Chicago, Chicago, IL, USA.
  • Gil-Prieto R; Harvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA, USA; Department of Preventive Medicine and Public Health, Rey Juan Carlos University, Madrid, Spain.
  • Griffin MR; Department of Health Policy, Vanderbilt University, Nashville, TN, USA.
  • Jin R; Harvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA, USA.
  • Lin ND; Optum, Waltham, MA, USA.
  • McMahill-Walraven CN; Data Science Department, Aetna, Blue Bell, PA, USA.
  • Reidy M; Harvard Pilgrim Health Care Institute and Department of Population Medicine, Harvard Medical School, Boston, MA, USA.
  • Selvam N; Government and Academic Research, HealthCore, Inc., Alexandria, VA, USA.
  • Selvan MS; Comprehensive Health Insights, Inc., Humana Inc., Louisville, KY, USA.
  • Nguyen MD; Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
Vaccine ; 34(1): 172-8, 2016 Jan 02.
Article en En | MEDLINE | ID: mdl-26549364
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Tromboembolia Venosa / Vacuna Tetravalente Recombinante contra el Virus del Papiloma Humano Tipos 6, 11 , 16, 18 Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Tromboembolia Venosa / Vacuna Tetravalente Recombinante contra el Virus del Papiloma Humano Tipos 6, 11 , 16, 18 Tipo de estudio: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Female / Humans País/Región como asunto: America do norte Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article Pais de publicación: Países Bajos